CANC Holdings Information

CANC is an equity ETF with a total of 56 individual holdings. The top holdings are Revolution Medicines stock at 6.36%, BridgeBio Pharma at 4.88%, Novartis AG at 4.88%, AstraZeneca at 4.54%, and Eli Lilly and Company at 4.23%.

Total Holdings

Top 10 Percentage

43.71%

Asset Class

Equity

ETF Category

Health

Assets

159.88M

PE Ratio

19.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	6.36%	98,581
2	BBIO	BridgeBio Pharma, Inc.	4.88%	114,318
3	SWX: NOVN	Novartis AG	4.88%	46,684
4	LON: AZN	AstraZeneca PLC	4.54%	35,320
5	LLY	Eli Lilly and Company	4.23%	6,565
6	BMY	Bristol-Myers Squibb Company	4.17%	108,187
7	RHHBY	Roche Holding AG	4.06%	108,952
8	MRK	Merck & Co., Inc.	3.74%	49,630
9	ACLX	Arcellx, Inc.	3.48%	48,346
10	COGT	Cogent Biosciences, Inc.	3.37%	135,358
11	NUVL	Nuvalent, Inc.	3.23%	49,239
12	GMAB	Genmab A/S	3.13%	169,724
13	IMNM	Immunome, Inc.	2.70%	195,451
14	JNJ	Johnson & Johnson	2.50%	16,257
15	CELC	Celcuity Inc.	2.48%	35,371
16	AMGN	Amgen Inc.	2.42%	10,122
17	ABBV	AbbVie Inc.	2.37%	16,712
18	EXEL	Exelixis, Inc.	2.23%	79,639
19	ONC	BeOne Medicines AG	1.82%	8,960
20	IDYA	IDEAYA Biosciences, Inc.	1.80%	89,238
21	SNDX	Syndax Pharmaceuticals, Inc.	1.66%	127,353
22	CGON	CG Oncology, Inc.	1.63%	45,885
23	ZLAB	Zai Lab Limited	1.51%	121,279
24	ZYME	Zymeworks Inc.	1.45%	96,723
25	ERAS	Erasca, Inc.	1.45%	169,487

Showing 25 of 56 holdings

Subscribe to see the full list

Activate Now

As of Feb 26, 2026